News Whistleblower lawsuit claims Takeda concealed harms of diabetes drug BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2002 (Published 13 March 2012) Cite this as: BMJ 2012;344:e2002 Article Related content Metrics Responses Peer review Related articles News FDA places greater restrictions on access to rosiglitazone Published: 24 September 2010; BMJ 341 doi:10.1136/bmj.c5287 News European regulatory body recommends suspension of rosiglitazone Published: 24 September 2010; BMJ 341 doi:10.1136/bmj.c5291 Research Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study Published: 19 August 2009; BMJ 339 doi:10.1136/bmj.b2942 See more Many more people could benefit from blood pressure lowering drugs, say researchers BMJ April 30, 2021, 373 n1120; DOI: https://doi.org/10.1136/bmj.n1120 Two thirds of female cardiologists have experienced discrimination, survey finds BMJ March 17, 2021, 372 n748; DOI: https://doi.org/10.1136/bmj.n748 Pulse oximetry may underestimate hypoxaemia in black patients, study finds BMJ December 21, 2020, 371 m4926; DOI: https://doi.org/10.1136/bmj.m4926 Partha Kar: Our approach to tackling obesity needs rethinking BMJ August 06, 2020, 370 m3034; DOI: https://doi.org/10.1136/bmj.m3034 National registry will record patient outcomes from devices implanted during vascular surgery BMJ July 24, 2020, 370 m2981; DOI: https://doi.org/10.1136/bmj.m2981
